✦ LIBER ✦

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials

✍ Scribed by Bohm, M.; Baumhakel, M.; Teo, K.; Sleight, P.; Probstfield, J.; Gao, P.; Mann, J. F.; Diaz, R.; Dagenais, G. R.; Jennings, G. L. R.; Liu, L.; Jansky, P.; Yusuf, S.

Book ID: 121346106
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 573 KB
Volume: 121
Category: Article
ISSN: 0009-7322
DOI: 10.1161/CIRCULATIONAHA.109.864199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erectile Dysfunction Predicts Cardiovasc

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials

✍ Shindel, A. 📂 Article 📅 2011 🏛 Elsevier Science ⚖ 46 KB

Rationale, design, and baseline characte

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Sexual function, satisfaction, and assoc

Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)

✍ Michael Böhm; Magnus Baumhäkel; Jeffrey L. Probstfield; Roland Schmieder; Salim 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 229 KB

The cardiac MRI substudy to ongoing telm

The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics

✍ Brett R. Cowan; Alistair A. Young; Craig Anderson; Robert N. Doughty; Rungroj Kr 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 414 KB

Effects of Telmisartan, Ramipril, and Th

Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease

✍ Verdecchia, P.; Sleight, P.; Mancia, G.; Fagard, R.; Trimarco, B.; Schmieder, R. 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 690 KB